Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

July 07, 2026 The Manager, Listing Department BSE Limited The National Stock Exchange of India Ltd. Corporate Relationship Department, Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai – 400 051 Dalal Street, Mumbai – 400 001 NSE Symbol: PANACEABIO BSE Scrip Code: 531349 Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Re.: Updates in relation to receipt of four Awards dated March 19, 2026 from the Presiding Officer (in the rank of Additional District Judge) of Industrial Tribunal, S.A.S. Nagar, Mohali Dear Sir/Madam, This is in continuation to our earlier letter dated April 10, 2026, intimating about receipt of four (4) Awards dated March 19, 2026, from the Presiding Officer (in the rank of Additional District Judge) of Industrial Tribunal, S.A.S. Nagar, Mohali. In this regard, we would like to inform you that the Company has, on July 06, 2026, filed appeals before the Hon’ble High Court of Punjab and Haryana, Chandigarh, against three (3) Awards. The Company is also in the process of filing an appeal against the remaining 4th Award and will update the same in due course. The updated requisite details as required under Regulation 30 of the SEBI LODR Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, and Industry Standards on Regulation 30 of SEBI LODR Regulations, are annexed herewith as Annexure A. This is for your kind information and record please. Kindly acknowledge the receipt. Thanking you, Sincerely yours, For Panacea Biotec Limited Ankit Jain General Manager – Legal and Company Secretary Panacea Biotec Limited (CIN: L33117PB1984PLC022350) Registered Office : Ambala-Chandigarh Highway, Lalru – 140501, Punjab Correspondence/Corporate office : B-1 Extn../A-27, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Fax: 91-11-4167 9015 Email: corporate@panaceabiotec.com Annexure A Details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”) read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, and Industry Standards on Regulation 30 of SEBI LODR Regulations S. No. Particulars Details 1. Name of the Listed Entity Panacea Biotec Limited 2. Type of communication received The Company has received four Awards from the Presiding Officer (in the rank of Additional District Judge) of Industrial Tribunal, S.A.S Nagar, Mohali 3. Date of receipt of communication 9 April 2026 4. Authority from whom communication Presiding Officer (in the rank of Additional received District Judge) of Industrial Tribunal, S.A.S Nagar, Mohali 5. Brief summary of the material Received the aforesaid Awards whereby the contents of the communication Tribunal has, inter-alia: received, including reasons for receipt 1. Set aside transfer of 23 workmen and of the communication granted relief of full back wages from the date of transfer; 2. Awarded reasonable wage revision for the workmen; and 3. Awarded reinstatement of the workers (other than those who have settled the dispute) with 50% back wages from the date of termination. 6. Period for which communication From 2014 onwards would be applicable, if stated 7. Expected financial implications on Based on the legal position / opinion, the the listed company, if any Company believes that the aforesaid Awards are challengeable, and the Company does not foresee any material adverse impact on its financial, operational, or other activities arising from these Awards. 8. Details of any aberrations/non- Not Applicable compliances identified by the authority in the communication 9. Details of any penalty or restriction or Not Applicable sanction imposed pursuant to the communication 10. Action(s) taken by listed company The Company has, on July 06, 2026, filed with respect to the communication appeals before the Hon’ble High Court of Punjab and Haryana, Chandigarh, against three (3) Awards. The Company is also in the process of filing an appeal against the remaining 4th Award. 11. Any other relevant information Not Applicable Panacea Biotec Limited (CIN: L33117PB1984PLC022350) Registered Office : Ambala-Chandigarh Highway, Lalru – 140501, Punjab Correspondence/Corporate office : B-1 Extn../A-27, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Fax: 91-11-4167 9015 Email: corporate@panaceabiotec.com